ASAM Opioid Use Disorder Treatment Application Survey

The American Society of Addiction Medicine (ASAM) is seeking experts to participate in the update of its National Practice Guideline for the Treatment of Opioid Use Disorder (NPG). As part of this effort, ASAM will also be convening a task force to consider how the update to the NPG can better address health disparities in the delivery of evidence-based care for OUD. Individuals can apply either to serve on the Guideline Committee, Health Disparities Task Force, or both.

Guideline Committee
The NPG was last updated in 2020, and the clinical recommendations in the current version are out-of-date, and do not address neither high-dose or low-dose initiation of buprenorphine, nor treatment in hospital settings. The guideline committee will be tasked with reviewing an updated systematic literature review and drafting recommendation statements using a GRADE and modified Delphi process for clinical consensus.

Health Disparities Task Force
OUD and overdose deaths disproportionately affect minoritized populations, particularly Black, Latino, and Indigenous communities, who also face significant barriers to receiving quality evidence-based treatment, especially medications for OUD (MOUD). ASAM is convening a task force to inform updates to its NPG, with a focus on identifying and reducing disparities in OUD treatment.

Estimated Time Commitment
Guideline committee members can expect to commit 1 hour per week for calls and approximately 6 additional hours per month (depending on the phase of the project) to review materials and draft content, for a total of 8-10 hours per month. The work of the guideline committee is anticipated to begin in August 2025 and be completed in early 2027.

Health Disparities task force members can expect to commit 2-4 hours per month for calls and approximately 6 additional hours per month to review materials and draft content, for a total of 8-10 hours per month. The work of the task force is anticipated to begin in June 2025 and be completed in early 2026.

Please note that we ask for an updated CV and a disclosure form as part of this application. The deadline for submissions is Friday, June 13, 2025.

If there are any questions, please contact Ms. Taleen Safarian at: tsafarian@asam.org.

Question Title

* 1. Name

Question Title

* 2. Designation

Question Title

* 3. Email Address

Question Title

* 4. Which group are you interested in joining?

Question Title

* 5. State where you are located

Question Title

* 6. Place of Employment

Question Title

* 7. Which category describes you? Please check all that apply

Question Title

* 8. Practice Setting(s)

Question Title

* 9. How many years of experience do you have in treating opioid use disorder?

Question Title

* 10. At what levels of care do you have experience in treating opioid use disorder?

Question Title

* 11. What are the biggest challenges you have faced in treating OUD?

Question Title

* 12. What would be your top three priorities in terms of recommendation updates you would like to see in this guideline?

Question Title

* 13. What is your experience (research or clinical) in addressing health disparities in OUD treatment? Please include the nature of your work and approximate years of involvement.

Question Title

* 14. What do you believe are the most significant issues contributing to disparities in SUD treatment across the field?

Question Title

* 15. Where do you see opportunities for change to improve equity in SUD treatment?

Question Title

* 16. Are you currently a member of ASAM?

Question Title

* 17. Do you currently serve on any ASAM committees?

Question Title

* 18. What is your race?

Question Title

* 19. What is your ethnicity?

Question Title

* 20. What is your gender identity?

Question Title

* 21. Please describe the diversity of the population that you primarily serve.

Question Title

* 22. Can you commit to the time commitment specified above?

Question Title

* 23. Please attach your CV.

Question Title

* 24. To be considered for the guideline committee or task force, you must complete ASAM’s Disclosure form HERE.